Six lncRNAs ( AL050303 , LINC00707, LINC01324, RP11-85G21, RP4-794I6.4, and RP5-855F16) have been shown to affect MAPK pathways, immune and inflammatory responses, and focal adhesion pathways, thereby suggesting that they may be significant in the prognosis of patients with melanoma [ 203 ].
1
—
—